MAP4K1 and neoplasm: To further confirm the expression of identified risk genes from network‐based analysis, RT‐QPCR assay of five hub genes (CD19, FGF2, MAP4K1, DCN and STAT6) were performed between 50 normal kidney samples and 50 ccRCC tumour samples.